Search Results

DNAnexus, Inc. today announced that it will collaborate with Oracle to advance precision health.

Element Biosciences, Inc., developer of pioneering technologies to empower science, announced a collaboration with DNAnexus, provider of the Precision Health Data Cloud, to allow customers to stream data from Element’s AVITI™ System directly to their DNAnexus account.

DNAnexus, Inc. and Curio Bioscience today announced a collaboration to streamline and simplify data analysis for high-resolution, whole transcriptome spatial mapping studies.

DNAnexus, Inc. , the provider of the Precision Health Data Cloud, and TMA Precision Health today announced a collaboration to advance basic and translational research for patients who have a rare disease.

DNAnexus, Inc. today announced a partnership to simplify and accelerate variant interpretation and clinical reporting.

DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced a collaboration to help streamline Discovery’s next-generation sequencing data analysis.

DNAnexus, Inc., provider of the Precision Health Data Cloud, and LORENZ Life Sciences Group, the leader in regulatory information management technology for the life sciences industry, today announced a partnership to offer Trusted Regulatory Spaces — secure, cloud-native environments that improve the submission validation process and ease of sponsor-reviewer communication for human drug and biologics applications to health authorities.

DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, announced that Thomas Laur has been appointed Chief Executive Officer and member of the company’s Board of Directors, effective September 11, 2023.

DNAnexus, Inc., the premier precision health data cloud provider, today announced the speaker lineup for its presentations at the American Society of Human Genetics (ASHG) Annual Meeting 2023, which is being held in Washington, D.C., this week.

DNAnexus Inc. today announced that Fore Genomics, a proactive genetic testing company designed for healthy newborns, infants, and children, is using the DNAnexus platform for its FORESITE 360 test.